FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969277997> ?p ?o ?g. }

• W2969277997 endingPage "286" @default.
• W2969277997 startingPage "275" @default.
• W2969277997 abstract "Background Venous percutaneous transluminal angioplasty (vPTA) in patients with multiple sclerosis (MS) and chronic cerebrospinal venous insufficiency (CCSVI) have shown contradictory results. The aim of the study is to evaluate the efficacy of the procedure in a randomized wait list control study. Methods 66 adults with neurologist-confirmed diagnosis of MS and sonographic diagnosis of CCSVI were allocated into vPTA-yes group (n = 31) or vPTA-not group (n = 35, control group). vPTA was performed immediately 15 days after randomization in the PTA-yes group and 6 months later in the control group. Evoked potentials (EPs), clinical-functional measures (CFMs), and upper limb kinematic measures (ULKMs) were measured at baseline (T0) and six months after in both groups, just before the venous angioplasty in the vPTA-not group (T1). Results Comparing the vPTA-yes and vPTA-not group, the CFM-derived composite functional outcome showed 11 (37%) versus 7 (20%) improved, 1 (3%) versus 3 (8%) stable, 0 versus 7 (20%) worsened, and 19 (61%) versus 18 (51%) mixed patients (χ2 = 8.71, df = 3, P = 0.03). Unadjusted and adjusted (for baseline confounding variables) odds ratio at 95% confidence interval were, respectively, 1.93 (1.3-2.8), P value 0.0007, and 1.85 (1.2-1.7), P value 0.002. EP- and ULKM-derived composite functional outcome showed no significant difference between the two groups. Conclusions Venous angioplasty can positively impact a few CFMs especially for the quality of life but achieving disability improvement is unlikely. Venous percutaneous transluminal angioplasty (vPTA) in patients with multiple sclerosis (MS) and chronic cerebrospinal venous insufficiency (CCSVI) have shown contradictory results. The aim of the study is to evaluate the efficacy of the procedure in a randomized wait list control study. 66 adults with neurologist-confirmed diagnosis of MS and sonographic diagnosis of CCSVI were allocated into vPTA-yes group (n = 31) or vPTA-not group (n = 35, control group). vPTA was performed immediately 15 days after randomization in the PTA-yes group and 6 months later in the control group. Evoked potentials (EPs), clinical-functional measures (CFMs), and upper limb kinematic measures (ULKMs) were measured at baseline (T0) and six months after in both groups, just before the venous angioplasty in the vPTA-not group (T1). Comparing the vPTA-yes and vPTA-not group, the CFM-derived composite functional outcome showed 11 (37%) versus 7 (20%) improved, 1 (3%) versus 3 (8%) stable, 0 versus 7 (20%) worsened, and 19 (61%) versus 18 (51%) mixed patients (χ2 = 8.71, df = 3, P = 0.03). Unadjusted and adjusted (for baseline confounding variables) odds ratio at 95% confidence interval were, respectively, 1.93 (1.3-2.8), P value 0.0007, and 1.85 (1.2-1.7), P value 0.002. EP- and ULKM-derived composite functional outcome showed no significant difference between the two groups. Venous angioplasty can positively impact a few CFMs especially for the quality of life but achieving disability improvement is unlikely." @default.
• W2969277997 created "2019-08-29" @default.
• W2969277997 creator A5005358830 @default.
• W2969277997 creator A5008644881 @default.
• W2969277997 creator A5024112851 @default.
• W2969277997 creator A5024429017 @default.
• W2969277997 creator A5031623451 @default.
• W2969277997 creator A5041370893 @default.
• W2969277997 creator A5041402471 @default.
• W2969277997 creator A5063904462 @default.
• W2969277997 creator A5068225935 @default.
• W2969277997 creator A5068380031 @default.
• W2969277997 creator A5080964854 @default.
• W2969277997 creator A5082530887 @default.
• W2969277997 creator A5087505202 @default.
• W2969277997 creator A5090381547 @default.
• W2969277997 date "2020-01-01" @default.
• W2969277997 modified "2023-10-14" @default.
• W2969277997 title "Percutaneous Venous Angioplasty in Patients with Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency: A Randomized Wait List Control Study" @default.
• W2969277997 cites W1982495693 @default.
• W2969277997 cites W1991949937 @default.
• W2969277997 cites W1994476850 @default.
• W2969277997 cites W1994673194 @default.
• W2969277997 cites W2023631102 @default.
• W2969277997 cites W2026132223 @default.
• W2969277997 cites W2026344558 @default.
• W2969277997 cites W2028844160 @default.
• W2969277997 cites W2058432955 @default.
• W2969277997 cites W2059676720 @default.
• W2969277997 cites W2065765997 @default.
• W2969277997 cites W2074235483 @default.
• W2969277997 cites W2080190205 @default.
• W2969277997 cites W2087589796 @default.
• W2969277997 cites W2105490558 @default.
• W2969277997 cites W2105656249 @default.
• W2969277997 cites W2107128347 @default.
• W2969277997 cites W2121572293 @default.
• W2969277997 cites W2122385128 @default.
• W2969277997 cites W2122545833 @default.
• W2969277997 cites W2130075988 @default.
• W2969277997 cites W2132268984 @default.
• W2969277997 cites W2136078048 @default.
• W2969277997 cites W2140516254 @default.
• W2969277997 cites W2150583762 @default.
• W2969277997 cites W2170689912 @default.
• W2969277997 cites W2335886232 @default.
• W2969277997 cites W2337802900 @default.
• W2969277997 cites W2592179495 @default.
• W2969277997 cites W2613542592 @default.
• W2969277997 cites W2770694056 @default.
• W2969277997 cites W2782590512 @default.
• W2969277997 cites W2787350822 @default.
• W2969277997 doi "https://doi.org/10.1016/j.avsg.2019.05.018" @default.
• W2969277997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31445091" @default.
• W2969277997 hasPublicationYear "2020" @default.
• W2969277997 type Work @default.
• W2969277997 sameAs 2969277997 @default.
• W2969277997 citedByCount "9" @default.
• W2969277997 countsByYear W29692779972019 @default.
• W2969277997 countsByYear W29692779972020 @default.
• W2969277997 countsByYear W29692779972021 @default.
• W2969277997 countsByYear W29692779972022 @default.
• W2969277997 countsByYear W29692779972023 @default.
• W2969277997 crossrefType "journal-article" @default.
• W2969277997 hasAuthorship W2969277997A5005358830 @default.
• W2969277997 hasAuthorship W2969277997A5008644881 @default.
• W2969277997 hasAuthorship W2969277997A5024112851 @default.
• W2969277997 hasAuthorship W2969277997A5024429017 @default.
• W2969277997 hasAuthorship W2969277997A5031623451 @default.
• W2969277997 hasAuthorship W2969277997A5041370893 @default.
• W2969277997 hasAuthorship W2969277997A5041402471 @default.
• W2969277997 hasAuthorship W2969277997A5063904462 @default.
• W2969277997 hasAuthorship W2969277997A5068225935 @default.
• W2969277997 hasAuthorship W2969277997A5068380031 @default.
• W2969277997 hasAuthorship W2969277997A5080964854 @default.
• W2969277997 hasAuthorship W2969277997A5082530887 @default.
• W2969277997 hasAuthorship W2969277997A5087505202 @default.
• W2969277997 hasAuthorship W2969277997A5090381547 @default.
• W2969277997 hasBestOaLocation W29692779972 @default.
• W2969277997 hasConcept C126322002 @default.
• W2969277997 hasConcept C141071460 @default.
• W2969277997 hasConcept C156957248 @default.
• W2969277997 hasConcept C159110408 @default.
• W2969277997 hasConcept C168563851 @default.
• W2969277997 hasConcept C204243189 @default.
• W2969277997 hasConcept C2779951463 @default.
• W2969277997 hasConcept C2780326628 @default.
• W2969277997 hasConcept C2780813298 @default.
• W2969277997 hasConcept C44249647 @default.
• W2969277997 hasConcept C71924100 @default.
• W2969277997 hasConcept C77350462 @default.
• W2969277997 hasConceptScore W2969277997C126322002 @default.
• W2969277997 hasConceptScore W2969277997C141071460 @default.
• W2969277997 hasConceptScore W2969277997C156957248 @default.
• W2969277997 hasConceptScore W2969277997C159110408 @default.
• W2969277997 hasConceptScore W2969277997C168563851 @default.
• W2969277997 hasConceptScore W2969277997C204243189 @default.
• W2969277997 hasConceptScore W2969277997C2779951463 @default.

• next